Order Article Reprints

Sachpekidis C, Dimitrakopoulou-Strauss A, Delorme S, Goldschmidt H. Functional Imaging with ¹⁸F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient. Diagnostics. 2017; 7(4):61. https://doi.org/10.3390/diagnostics7040061

Sachpekidis, Christos, Antonia Dimitrakopoulou-Strauss, Stefan Delorme, and Hartmut Goldschmidt. 2017. "Functional Imaging with ¹⁸F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient" Diagnostics 7, no. 4: 61. https://doi.org/10.3390/diagnostics7040061

Sachpekidis, C., Dimitrakopoulou-Strauss, A., Delorme, S., & Goldschmidt, H. (2017). Functional Imaging with ¹⁸F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient. Diagnostics, 7(4), 61. https://doi.org/10.3390/diagnostics7040061